title: Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.
abstract: Chemotherapy-induced peripheral neuropathies (CIPNs) are an increasingly common neuropathic and pain syndrome in adult and pediatric cancer patients and survivors [1-69]. However, symptoms associated with CIPNs are often undiagnosed, under-assessed, and communications problems between clinicians, family members, and patients have been observed [70-73]. Less is known about the prevalence and impact of CIPNs on pediatric cancer populations [70-71]. This article aims to provide a brief understanding of CIPNs in pediatric populations, and to review the evidence for both its prevention and treatment.
authors.affiliation: FDA, Clinical Center, National Institutes of Health, Bethesda, MD.
authors.forename: Rhonda J
authors.initials: RJ
authors.lastname: Moore
authors.affiliation: FDA, Clinical Center, National Institutes of Health, Bethesda, MD.
authors.forename: Hunter
authors.initials: H
authors.lastname: Groninger
keywords: cancer pain; chemotherapy induced peripheral neuropathy; communication; pediatric pain